C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor

Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
11/2001
11/20/2001	US6320026 Polypeptide for use in the prevention and treatment of tumors
11/20/2001	US6319716 Generating expression vectors; link heterologous sequences, insert into cells, allow homologous recombination, recover expression vectors
11/20/2001	US6319706 Device for use in the bioremediation of polluted soils
11/20/2001	US6319704 Nucleotide sequences coding an enzymatic polypeptide; for use in the diagnosis and treatment of nervous system disorders
11/20/2001	US6319702 Nucleotide sequencs coding an enzymatic polypeptide and cell targeting compound; for use in treatment of cancer
11/20/2001	US6319699 Bacterial strains and use thereof in fermentation processes for 2-keto-l-gulonic acid protection
11/20/2001	US6319693 Cloning of chicken anemia virus DNA
11/20/2001	US6319692 Insertion of exogenous nucleotides equences into bacteria; generate vector, insert into bacterial genome, recover adjusted bacteria
11/20/2001	US6319689 Nucleotide sequence which code aspartic protease; for treatment of alzheimer's disease, cancer; for hormone processing
11/20/2001	US6319688 Polynucleotide encoding human sodium dependent phosphate transporter (IPT-1)
11/20/2001	US6319686 Nucleotide sequences coding binding protein; for use as diagnostic, drug design and therapeutic tools
11/20/2001	US6319685 Polypeptide for generation of amidated agricultral and medical products
11/20/2001	US6318387 Parts washing system
11/20/2001	CA2163015C 5' nucleases derived from thermostable dna polymerase
11/19/2001	CA2324167A1 A membrane-bound netrin
11/15/2001	WO2001086293A2 A method for designing and screening random libraries of compounds
11/15/2001	WO2001085993A2 Method for detecting growth hormone variations in humans, the variations and their uses
11/15/2001	WO2001085980A2 Enzymatic assays for screening anti-cancer agents
11/15/2001	WO2001085966A2 Modification of bacteria
11/15/2001	WO2001085956A2 Lipid metabolism enzymes
11/15/2001	WO2001085955A1 Rh116 polypeptides and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
11/15/2001	WO2001085954A2 Serine-threonine kinase-3
11/15/2001	WO2001085952A2 Modified inosine 5'-monophosphate dehydrogenase polypeptides and uses thereof
11/15/2001	WO2001085950A2 Genes of the 1-desoxy-d-xylulose biosynthesis path
11/15/2001	WO2001085948A2 Nucleotide sequences which code for the coryneform acyl carrier protein gene
11/15/2001	WO2001085947A2 Compounds and methods for the diagnosis and treatment of babesia microti infection
11/15/2001	WO2001085946A2 Nucleic acid molecules encoding plant cell cycle proteins and uses therefor
11/15/2001	WO2001085944A2 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor
11/15/2001	WO2001085942A2 Cytoskeleton-associated proteins
11/15/2001	WO2001085937A2 Regulator of g protein signalling (rgs8)
11/15/2001	WO2001085936A1 F-box containing protein
11/15/2001	WO2001085935A2 Endothelial differentiation gene 6-like g protein coupled receptor
11/15/2001	WO2001085934A1 New ras guanine-nucleotide-exchange factor 1 (nrg1)
11/15/2001	WO2001085933A2 Plakoglobin interacting proteins
11/15/2001	WO2001085926A2 Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate
11/15/2001	WO2001085921A2 Human serine-threonine kinase-4
11/15/2001	WO2001085916A1 A medium material selectively culturing prokaryote comprising rotting organic wastes and a method for cultivating crops using same
11/15/2001	WO2001085905A2 Isolated gum operon from xyllela fastidiosa, isolated nucleic acid molecules therefrom, and uses thereof
11/15/2001	WO2001085797A1 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system
11/15/2001	WO2001085793A2 G protein-coupled receptors
11/15/2001	WO2001085792A2 Mu-1, member of the cytokine receptor family
11/15/2001	WO2001085790A2 Mammalian cytokine receptor subunit proteins, related reagents and methods
11/15/2001	WO2001085785A2 Ph domain-interacting protein
11/15/2001	WO2001085779A2 Protein complexes and assays for screening anti-cancer agents
11/15/2001	WO2001085772A2 Virulence genes, proteins, and their use
11/15/2001	WO2001085766A2 Novel eosinophil cationic proteins used in the treatment of asthmatic and allergic disorders
11/15/2001	WO2001085762A2 Cancer diagnosis and assays for screening anti-cancer agents
11/15/2001	WO2001085757A2 Purification of protein inclusion bodies by crossflow microfiltration
11/15/2001	WO2001085664A2 Compounds and methods for regulating bacterial growth and pathogenesis
11/15/2001	WO2001085340A2 Method for the identification, quantification, and visualisation of micro-organisms
11/15/2001	WO2001085191A1 Hyaluronidase activity and allergenic cell activity inhibitor
11/15/2001	WO2001085187A1 Use of hydrogenotrophic acetogenic strains for preventing or treating digestive disorders
11/15/2001	WO2001085186A1 Preparation that contains the intestinal beneficial bacterium fermentation culture
11/15/2001	WO2001036001A3 Interferon gamma conjugates
11/15/2001	WO2001032882A3 Nucleic acids and proteins from group b streptococcus
11/15/2001	WO2001032878A3 A novel polypeptide hormone phosphatonin
11/15/2001	WO2001019974A3 Recombinant microorganisms
11/15/2001	WO2001016292A8 37 staphylococcus aureus genes and polypeptides
11/15/2001	WO2001002594A3 DNA CONSTRUCTS BASED ON THE eIF4A GENE PROMOTER
11/15/2001	WO2001002550A3 Cell death related drug targets in yeast and fungi
11/15/2001	WO2000053232A9 Matriptase, a serine protease and its applications
11/15/2001	WO2000052141A9 Cells resistant to toxic genes and uses thereof
11/15/2001	WO2000031245A8 Creatine amidinohydrolase and process for producing the same
11/15/2001	WO2000026370A9 Adenine nucleotide translocator (ant) fusion proteins and uses thereof
11/15/2001	US20010041787 Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast
11/15/2001	US20010041361 Method for enhanced protein stabilization and for production of cell lines useful for production of such stabilized proteins
11/15/2001	US20010041358 Method of producing a polyunsaturated fatty acid containing culture and polyunsaturated fatty acid containing oil using microorganisms
11/15/2001	US20010041354 Genetic engineering
11/15/2001	US20010041333 High throughput screening for a bioactivity or biomolecule
11/15/2001	US20010041331 Methods of utilizing the TT virus
11/15/2001	DE10023400A1 New acyl-carrier protein gene, acp, from coryneform bacteria, useful for increasing fermentative production of amino acids, especially lysine
11/15/2001	DE10022362A1 Verfahren zum Auffinden von Modulatoren von Enzymen des Carotenoid-Biosyntheseweges A method for finding modulators of enzymes of the carotenoid biosynthesis pathway
11/15/2001	DE10022258A1 Purification and/or concentration of protein inclusion bodies in solution, by passing the solution tangentially across semipermeable membrane formed from intersecting longitudinal and transverse fibers
11/15/2001	DE10021731A1 Cyclipostine, Verfahren zu ihrer Herstellung und Verwendung derselben Cyclipostins, processes for their preparation and use thereof
11/15/2001	DE10021688A1 New DNA sequences involved in isoprenoid biosynthesis, useful in screening for compounds with e.g. antimicrobial and herbicidal activity
11/15/2001	CA2409714A1 Modification of bacteria
11/15/2001	CA2409515A1 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system
11/15/2001	CA2409510A1 Method for detecting growth hormone variations in humans, the variations and their uses
11/15/2001	CA2408921A1 Modified inosine 5'-monophosphate dehydrogenase polypeptides and uses thereof
11/15/2001	CA2408828A1 Novel serine-threonine kinase-4
11/15/2001	CA2408738A1 Virulence genes, proteins, and their use
11/15/2001	CA2408665A1 Novel regulator of g protein signalling
11/15/2001	CA2408664A1 F-box containing protein
11/15/2001	CA2408652A1 A method for designing and screening random libraries of compounds
11/15/2001	CA2408632A1 Ph domain-interacting protein
11/15/2001	CA2408576A1 Rh116 polypeptides and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
11/15/2001	CA2408571A1 Mammalian receptor proteins; related reagents and methods
11/15/2001	CA2408468A1 Serine-threonine kinase-3
11/15/2001	CA2408297A1 Cancer diagnosis and assays for screening anti-cancer agents
11/15/2001	CA2408213A1 Protein complexes and assays for screening anti-cancer agents
11/15/2001	CA2408051A1 Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate
11/15/2001	CA2408038A1 Nucleic acid molecules encoding plant cell cycle proteins and uses therefor
11/15/2001	CA2408002A1 Enzymatic assays for screening anti-cancer agents
11/15/2001	CA2407955A1 Genes of the 1-desoxy-d-xylulose biosynthesis path
11/15/2001	CA2407937A1 New ras guanine-nucleotide-exchange factor 1 (nrg1)
11/15/2001	CA2407886A1 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor
11/15/2001	CA2407865A1 Novel eosinophil cationic proteins used in the treatment of asthmatic and allergic disorders
11/15/2001	CA2407864A1 Lipid metabolism enzymes
11/15/2001	CA2407850A1 Cytoskeleton-associated proteins
11/14/2001	EP1154021A2 Polyhidroxyalkanoate synthase and gene encoding the same enzyme

1 ... 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 ... 1489